Incyte Corporation
NASDAQIncyte Corporation reported Q1 2026 results on April 28, and the market reacted better than bears expected — yet short sellers are still adding to positions, and options traders are hedging at an intensity not seen in months. The stock closed Tuesday at $99.10, up 1.4% on the day and 2.4% on the week. That follows a 10% rally over the past month, the kind of move that might…
Snapshot as of 7 May 2026
Incyte Corporation reported Q1 2026 results on April 28, and the market reacted better than bears expected — yet short sellers are still adding to positions, and options traders are hedging at an intensity not seen in…
Incyte Corporation trades at $96.74, up 6.6% over the past month despite a modest 0.4% dip this week. The biotech firm reports Q1 2026 results on April 28. Short interest sits at 5.79% of float. That's low for biotech.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INCY — free to start on ORTEX.
Sign up for free →Open INCY on ORTEX